Compare DXCM & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DXCM | EQR |
|---|---|---|
| Founded | 1999 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 22.5B |
| IPO Year | 2005 | 1993 |
| Metric | DXCM | EQR |
|---|---|---|
| Price | $67.34 | $62.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 11 |
| Target Price | ★ $86.86 | $70.00 |
| AVG Volume (30 Days) | ★ 4.8M | 2.1M |
| Earning Date | 02-12-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 4.42% |
| EPS Growth | 7.75 | ★ 24.49 |
| EPS | 1.80 | ★ 3.03 |
| Revenue | ★ $4,515,900,000.00 | $3,078,827,000.00 |
| Revenue This Year | $17.41 | $5.10 |
| Revenue Next Year | $12.78 | $3.51 |
| P/E Ratio | $37.52 | ★ $20.68 |
| Revenue Growth | ★ 14.21 | 4.69 |
| 52 Week Low | $54.11 | $58.38 |
| 52 Week High | $93.25 | $75.86 |
| Indicator | DXCM | EQR |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 61.82 |
| Support Level | $65.56 | $60.89 |
| Resistance Level | $67.95 | $62.52 |
| Average True Range (ATR) | 1.87 | 0.98 |
| MACD | 0.10 | 0.19 |
| Stochastic Oscillator | 59.27 | 91.28 |
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.